drugset / Trial / NCT06918418

A Comparative Study of Adding Ipratropium to Salbutamol for the Treatment of Asthma Attack in Children

NCT06918418

RandomizedParallel-groupSingle-blindTreatment

Summary

The goal of this clinical trial was to determine if adding ipratropium bromide to salbutamol improves asthma treatment in children. The main question this study aimed to answer was: Does combining ipratropium with salbutamol improve asthma symptoms more effectively than salbutamol alone? Researchers compared salbutamol alone to a combination of salbutamol and ipratropium in children with acute asthma. Participants: (i) Received either salbutamol alone or salbutamol with ipratropium via nebulization for 4 hours (ii) Had their asthma symptoms assessed before and after treatment (iii) Were discharged with continued treatment and counseling if stable This study was conducted in the Department of Pediatric Medicine, Children's Hospital Multan, over six months. A total of 60 children with acute asthma were included.

Timeline

Start
2024-01-01
Primary completion
2024-06-30
Completion
2024-07-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Ipratropium Small molecule 250 ug Inhaled
Subject Ipratropium Small molecule 500 ug Inhaled
Comparator Salbutamol Unknown 0.15 mg/kg Inhaled

Indications